Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Home > Publications > Research Monographs >    

Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Design

NIDA Research Monograph, Number 134 [Printed in 1993]

Get Adobe Reader

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph134.pdf - Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Design (2.9 MB)

Table of Contents

Strategies for Drug Discovery-----1
Michael Williams

Mass Ligand-Binding Screening Strategies for Identification of Leads for New Drug Discovery-----37
Ronald M. Burch

Antibody- and Peptide Structure-Based Drug Design-----46
Manfred E. Wolff

The Use of Cloned Human Receptors for Drug Design-----56
Paul R. Hartig

Synthetic Peptide Combinatorial Libraries May Be Used To Determine Peptide Ligands for Opioid Receptors-----66
Richard A. Houghten and Colette T. Dooley

Preparation of Large Peptide Libraries With One Peptide per Bead and Their Use for the Discovery of Peptides That Bind to Acceptors-----75
Victor J. Hruby, Kit S. Lam, Michal Lebl, Wieslaw Kazmierski, Evan M. Hersh, and Sydney E. Salmon

Computer Design of Bioactive Compounds Based on 3-D Properties of Ligands-----64
Y.C. Martin

Toward the Design of New Inhibitors: A Computer Modeling Approach-----103
Carlos H. Faerman

Efforts To Improve the Utilization of Protein Sequence and Structure Databases-----114
Nagarajan Pattabiraman and Krishnan Namboodiri

Use of Computer Graphics in Drug Design-----129
G. W.A. Milne and M.C. Nicklaus

Purification and Cloning of Opioid Receptors-----146
Ling-Yuan Li, Ying-Fu Su, Zeng-Ming Zhang, Chih-Shung Wong, and Kwen-Jen Chang

Computer-Assisted Design of Dopamine Transporter Ligands-----165
Gilda H. Loew, Hugo 0. Villar, Patricia A. Maguire, and M. Frances Davies

The Pharmacophore for Opioid Activity-----178
Mark Froimo witz

The Molecular Basis of Opioid Potency and Selectivity: Morphiceptins, Dermorphins, Deltorphins, and Enkephalins-----195
Murray Goodman, Seonggu Ro, George ůsapay, Toshimasa Yamazaki, and Alexander Polinsky

Molecular Determinants of Cannabinoid Activity: Toward the Design of Cannabinoid Analgesics With Reduced Psychoactive Liability-----210
Patricia H. Reggio

Cocaine Receptor: A Structure-Activity Relationship Study-----229
F. Ivy Carroll, Anita H. Lewin, Michael J. Kuhar, and John W. Baja

The Use of Conformational Restriction and Molecular Modeling Techniques in the Development of Receptor-Specific Opioid Peptide Agonists and Antagonists-----236
Peter W. Schiller, Thi M.-D. Nguyen, Grazyna Weltrowska, Nga N. Chung, Carole Lemieux, Brian J. Marsden, and Brian C. Wilkes

Probes for the Cannabinoid Sites of Action-----253
Alexandros Makriyannis

A Model for the Structural Basis of -Opiloid Receptor Selectivity-----266
Henry I. Mosberg and Frank Porreca

List of NIDA Research Monographs-----281

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal